5-PLASMA Bivalirudin Control, Model Number 5D-44905 — FDA record Z-2896-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jul 1, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
5-PLASMA Bivalirudin Control, Model Number 5D-44905
Reason
Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.
Classification
Class II
Recalling firm
Aniara Diagnostica LLC
Quantity
9 units
Agency-reported status
Ongoing
Source record identifier
Z-2896-2026

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: 05070002420385, Lot Number: KE132602

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of IL, NC, TN.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Aug 12, 2026
Recall initiation date
Jul 1, 2026
Center classification date
Aug 5, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records